Ltd. was founded in June 2002, with a registered capital of 130 million yuan, headquartered in the famous historical and cultural city of Jinan, Shandong Province, which is surrounded by lotus flowers and willows, and a city of mountains and half a city of lakes. It is a high-tech enterprise focusing on the research and development, production, sales and service of pharmaceutical APIs, intermediates and fine chemicals, and is committed to the research and development and application of new technologies in the fields of MAH, CDMO, veterinary medicine and agrochemicals, etc. The Group now has one R&D center, which is located in Jinan, Shandong Province. The group now has one R&D center-Shandong Chengchuang Blue Ocean Pharmaceutical Technology Co., Ltd, one API factory-Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. and two pharmaceutical intermediates production bases, with more than 1,000 employees, and more than 300 R&D team members.
Products
GMP
Lidocaine Hydrochloride, Lidocaine, Bupivacaine Hydrochloride, Procainamide, Celecoxib, Sugar Glucose Sodium, Ozagrel Sodium, Lacidipine, Urapidil Hydrochloride
State I
Vonorasan fumarate, Cliborol , ropivacaine hydrochloride, bupivacaine, bupivacaine hydrochloride, ativacaine hydrochloride
Reported CEP
Mildronate (approved), ropivacaine hydrochloride (under review), ativacaine hydrochloride (under review)
US-DMF
Proparacaine hydrochloride, bupivacaine, pramoxine hydrochloride, vonorasan fumarate
under development
Letemovir, rucotinib, fenelidone, marbofloxacin, abatacept, tadalafil, florentina, aflatina, sarolana, etc.
*All our products are not offered in countries where valid patents exist. All responsibility with repect to third parties patent rights in specific countries lies exclusively with the buyers.
產(chǎn)品明細(xì)
| Product Name |
產(chǎn)品名稱 |
CAS |
| *Vonoprazan Fumarate |
富馬酸伏諾拉生 |
1260141-27-2
881681-01-2
|
| *Letermovir |
來特莫韋 |
917389-32-3 |
| *Dapagliflozin propanediol monohydrate |
達(dá)格列凈一水丙二醇 |
960404-48-2 |
| *Crisaborole |
克立硼羅 |
906673-24-3 |
| Prilocaine |
丙胺卡因 |
721-50-6 |
| Lidocaine hydrochloride |
鹽酸利多卡因 |
6108-05-0 |
| Lidocaine |
利多卡因 |
137-58-6 |
| Ozagrel sodium |
奧扎格雷鈉 |
189224-26-8 |
| Celecoxib |
塞來昔布 |
169590-42-5 |
| Ropivacaine hydrochloride |
鹽酸羅哌卡因 |
132112-35-7 |
| Sugammadex sodium |
舒更葡糖鈉 |
343306-79-6 |
| Tetracaine hydrochloride |
鹽酸丁卡因 |
136-47-0 |
| Tetracaine |
丁卡因 |
94-24-6 |
| Prilocaine hydrochloride |
鹽酸丙胺卡因 |
1786-81-8 |
| Pramoxine hydrochloride |
鹽酸普莫卡因 |
637-58-1 |
| Meldonium |
米屈肼 |
86426-17-7 |
| Bupivacaine hydrochloride |
鹽酸布比卡因 |
73360-54-0 |
| Bupivacaine |
布比卡因 |
2180-92-9 |
| Articaine hydrochloride |
鹽酸阿替卡因 |
23964-57-0 |
| Tadalafil |
他達(dá)那非 |
171596-29-5 |
| *Apalutamide |
阿帕他胺 |
956104-40-8 |
| *Baloxavir Marboxil |
瑪巴洛沙韋 |
1985606-14-1 |
| *Fluralaner |
氟雷拉納 |
864731-61-3 |
| *Afoxolaner |
阿福拉納 |
1093861-60-9 |
| *Sarolaner |
沙羅拉納 |
1398609-39-6 |
| *Ruxolitinib |
蘆可替尼 |
941678-49-5 |
| *Finerenone |
非奈利酮 |
1050477-31-0 |
| *Upadacitinib |
烏帕替尼 |
1310726-60-3 |
| Ozenoxacin |
奧澤沙星 |
245765-41-7 |
| Donepezil hydrochloride |
鹽酸多奈哌齊 |
120011-70-3 |
| Levobupivacaine hydrochloride |
鹽酸左布比卡因 |
27262-48-2 |
| Dibucaine hydrochloride |
鹽酸地布卡因 |
CAS：61-12-1 |
| Mepivacaine hydrochloride |
鹽酸甲哌卡因 |
1722-62-9 |
| Medetomidine hydrochloride |
鹽酸美托咪啶 |
86347-15-1 |
| Dyclonine hydrochloride |
鹽酸達(dá)克羅寧 |
536-43-6 |
| Dienogest |
地諾孕素 |
65928-58-7 |
| Altrenogest |
烯丙孕素/四烯雌酮 |
850-52-2 |
| Brexanolone |
5alpha-孕甾-3alpha-醇-20-酮 |
516-54-1 |
| Metoclopramide |
甲氧氯普胺（胃復(fù)安） |
364-62-5 |
| Brinzolamide |
布林佐胺 |
138890-62-7 |
| Terbinafine hydrochloride |
鹽酸特比萘芬 |
78628-80-5 |
| Mexidole |
美昔得樂 |
127464-43-1 |
| Dexmedetomidine hydrochloride |
鹽酸右美托咪定 |
145108-58-3 |
| Nadifloxacin |
那氟沙星 |
124858-35-1 |
|
富馬酸伏諾拉生中間體
Vonoprazan Fumarate Intermediates
|
| 5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde |
5-(2-氟苯基)-1H-吡咯-3-甲醛 |
881674-56-2 |
| Pyridine-3-sulfonyl chloride hydrochloride |
吡啶-3-磺酰氯 |
16133-25-8 |
|
達(dá)格列凈中間體
Dapagliflozin Intermediates
|
| 5-bromo-2-chloro-4’-ethoxydiphenylmethane |
5-溴-2-氯-4’-乙氧基二苯甲烷 |
461432-23-5 |
| [(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate |
(2R,3R,4R,5S,6S)-2-(乙酰氧基甲基)-6-(4-氯-3-(4-乙氧基芐基)苯基)四氫-2H-吡喃-3,4,5-三yl 三乙酸酯 |
461432-25-7 |
|
來特莫韋中間體
Letemovir Intermediates
|
|
2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)
-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl) acetic acid methyl ester
|
2-(8-氟-3-(2-甲氧基-5-(三氟甲基)苯基)-2-氧代-1,2,3,4-四氫喹唑啉-4-基)乙酸甲酯 |
917389-21-0 |
| 1-(3-Methoxyphenyl)Piperazine Hydrochloride |
1-(3-甲氧基苯基)哌嗪鹽酸鹽 |
16015-70-6 |
|
克立硼羅中間體
Crisaborole Intermediates
|
| 2-bromo-5-hydroxybenzaldehyde |
2-溴-5-羥基苯甲醛 |
2973-80-0 |
| 4-[4-bromo-3-(hydroxymethyl)phenoxy]benzonitrile |
4-[4-溴-3-(羥基甲基)苯氧基]苯甲腈 |
906673-45-8 |
| [2-bromo-5-(4-cyanophenoxy)phenyl]methyl acetate |
2-溴-5-（4-氰基苯氧基）乙酸芐酯 |
2227126-09-0 |
|
瑪巴洛沙韋中間體
Baloxavir Marboxil Intermediates
|
| (R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione |
(R)-7-(芐氧基)-3,4,12,12A-四氫-1H-[1,4]噁嗪[3,4-C]吡啶并[2,1-F] [1,2,4]三嗪-6,8二酮（巴沙洛韋母核） |
1985607-70-2 |
| 3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
3-(芐氧基)-4-氧代-4H-吡喃-2-羧酸 |
119736-16-2 |
| 7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol |
7,8 -二氟- 6,11 -二氫-二苯并[ B,E ]噻吩并- 11 -醇 |
1985607-83-7 |
|
非奈利酮中間體
Finerenone Intermediates
|
| 4-formyl-3-methoxybenzonitrile |
4-氰基-2-甲氧基苯甲醛 |
21962-45-8 |
| 4-amino-5-methylpyridone |
4-氨基-5-甲基-2-羥基吡啶 |
95306-64-2 |
| 2-cyanoethylacetoacetate |
2-氰基乙酰乙酸乙酯 |
65193-87-5 |
| 2-chloro-5-methylpyridin-4-amine |
2-氯-4-氨基-5-甲基吡啶 |
79055-62-2 |
|
阿帕他胺中間體
Apalutamide Intermediates
|
| 5-Amino-3-(trifluoromethyl)picolinonitrile |
5-氨基-3-(三氟甲基)氰基吡啶 |
573762-62-6 |
| N-Boc-1-aminocyclobutanecarboxylic acid |
Boc-1-氨基環(huán)丁烷羧酸 |
120728-10-1 |
| 1-amino-N-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]Cyclobutanecarboxamide |
1-氨基-N-[6-氰基-5-(三氟甲基)-3-吡啶基]-環(huán)丁烷甲酰胺 |
1950587-17-3 |
|
磷酸蘆可替尼中間體
Ruxolitinib Phosphate Intermediates
|
| 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
1-(1-乙氧基乙基)-4-吡唑硼酸頻哪醇酯 |
1029716-44-6 |
| 3-Cyclopentylacrylonitrile |
3-環(huán)戊基丙烯腈 |
591769-05-0 |
| (4-(1-(2-Cyano-1-cyclopentylethyl)-1h-pyrazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
(4-(1-(2-氰基-1-環(huán)戊基乙基)-1h-吡唑-4-基)-7h-吡咯并[2,3-d]嘧啶-7-基)特戊酸甲酯 |
1236033-05-8 |
|
烏帕替尼中間體
Upadacitinib Intermediates
|
| (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester |
|
1428243-26-8 |
| tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate |
|
1201187-44-1 |
| 8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine |
|
1428243-28-0 |
|
奧澤沙星中間體
Ozenoxacin Intermediates
|
| ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate |
奧澤沙星中間體A |
103877-51-6 |
| 5-broMo-N,3-diMethylpyridin-2-aMine |
奧澤沙星中間體B |
245765-66-6 |
| [6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid |
奧澤沙星中間體D |
446299-81-6 |
|
布林佐胺中間體
Brinzolamide Intermediates
|
| (S)-3,4-dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide |
(S)-6-氯-3,4-二氫-2H-噻吩并[3,2-e]-1,2-噻嗪-4-醇1,1-二氧化物 |
160982-16-1 |
| (S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide |
(S)-3,4-二氫-4-羥基-2-(3-甲氧基丙基)-2H-噻吩并[3,2-e]-1,2-噻嗪-6-磺胺-1,1-二氧化物 |
154127-42-1 |
|
鹽酸阿替卡因中間體
Articaine hydrochloride Intermediates
|
| 3-Amino-4-methyl-2-thiophene carboxylic acid methyl ester |
3-氨基-4-甲基噻吩-2-甲酸甲酯 |
85006-31-1 |
|
鹽酸羅哌卡因中間體
Ropivacaine Intermediates
|
| N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide |
|
15883-20-2 |
| (2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide |
|
27262-40-4 |
|
別孕酮中間體
Brexanolone Intermediates
|
| Allopregnan-3β-ol-20-one acetate |
別孕烯醇酮醋酸酯 |
906-83-2 |
| 3β-hydroxy-5α-pregnan-20-one |
別孕烯醇酮 |
516-55-2 |
|
氟雷拉納中間體
Fluralaner Intermediates
|
| 4-acetyl-2-methylbenzoic acid |
2-甲基-4-乙?；郊姿?/td>
| 55860-35-0 |
| 2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride |
2-氨基-N-(2,2,2-三氟乙基)乙酰胺鹽酸鹽 |
1171331-39-7 |
| 3',5'-DICHLORO-2,2,2-TRIFLUOROACETOPHENONE |
3', 5'-二氯-2, 2, 2-三氟苯乙酮 |
130336-16-2 |
|
阿福拉納中間體
Afoxolaner Intermediates
|
| 4-acetyl-1-naphthoic acid |
4-乙?；良姿?/td>
| 131986-05-5 |
| 2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride |
2-氨基-N-(2,2,2-三氟乙基)乙酰胺鹽酸鹽 |
1171331-39-7 |
| 1-[3-Chloro-5-trifluoromethylphenyl]-2,2,2-trifluoroethanone |
1-[3-氯-5-(三氟甲基)苯基]-2,2,2-三氟乙酮 |
1125812-58-9 |
*All our products are not offered in countries where valid patents exist. All responsibility with repect to third parties patent rights in specific countries lies exclusively with the buyers.
MAH Business
Based on the existing APIs, MAH business has carried out in-depth excavation of preparation projects and formed specialized MAH routes in niche areas, and 11 MAH projects have been carried out, among which the project of Sodium Sugar Glucose has been approved, and the preparation of Lidocaine has been submitted to the State Bureau to enter the clinical research stage.
CDMO Business
We can undertake the customization and service of high-end pharmaceutical intermediates, new agrochemical intermediates, veterinary intermediates such as pet drugs, and cross-border products and intermediates in the health category.
Contact us
Shandong Chenghui Pharmaceutical Group Co.
chenghui pharmaceutical group ltd
Pharmaceutical Business
Manager Shen 0531-58897066
Manager Liao 0531-58897055
Trading company business
Mr. Li 0531-58897086
Mr. Huang 0531-58897087
Manager Tang 0531-58897051
Veterinary medicine business
Mr. Ren 0531-58897165
Marketing Department
Manager Xie 0531-58897070
Recruitment
Mr. Li 0531-58897028
Mailbox
sales@jnchsd.com
market@jnchsd.com
Official website: www.jnchsd.com
Address：No.2350, Pioneering Road, Gaoxin District, Jinan City, Shandong Province, China.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
![3,3'-bi-9H-carbazole,9-[1'1-biphenyl]-4-yl-9'-phenyl](https://eimg.pharmasources.com/image/product/20240712/e5704886d936cc5ad08b71cf1ba3f217jpg)
Pharma Sources Insight January 2025
